Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION USP

Last updated on 2018-10-02 History
Report ID 8417
Drug Identification Number 02347830
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION USP
Common or Proper name ROPIVACAINE
Company Name PFIZER CANADA ULC
Active Ingredient(s) ROPIVACAINE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration BLOCK/INFILTRATION EPIDURAL
Packaging size 10x10mL
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-05-09
Estimated end date
Actual end date 2018-10-01
Shortage status Resolved
Updated date 2018-10-02
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v25 2018-10-02 French Compare
v24 2018-10-02 English Compare
v23 2018-09-24 French Compare
v22 2018-09-24 English Compare
v21 2018-09-06 French Compare
v20 2018-09-06 English Compare
v19 2018-06-18 French Compare
v18 2018-06-18 English Compare
v17 2018-05-02 French Compare
v16 2018-05-02 English Compare
v15 2018-04-05 French Compare
v14 2018-04-05 English Compare
v13 2018-02-03 French Compare
v12 2018-02-03 English Compare
v11 2017-12-15 French Compare
v10 2017-12-15 English Compare
v9 2017-11-21 French Compare
v8 2017-11-21 English Compare
v7 2017-07-31 French Compare
v6 2017-07-31 English Compare

Showing 1 to 20 of 25